Best Hospitals for Vasculitis treatment in Italy 2026

San Raffaele Research Hospital in Milan and Careggi University Hospital in Florence specialize in complex vasculitis. These IRCCS-accredited centers combine clinical research with advanced rheumatology. Italian facilities often serve as hubs within the European Reference Network (ERN RITA). This ensures standardized care for rare autoimmune diseases.

• San Raffaele hospital: Offers expert care for rare immune system and genetic diseases.
• Careggi university hospital: Features a dedicated Reference Center for Systemic Autoimmune Diseases.
• San Giovanni Bosco: Serves as a multidisciplinary hub for immunopathology and rare diseases.
• Specialized diagnostic methods: Hospitals utilize advanced vascular imaging and quick biopsies for diagnosis.

Bookimed Expert Insight: San Raffaele stands out by performing over 52,000 operations annually. It is one of Europe’s largest research hospitals. Most general hospitals lack this scale and IRCCS research status. Choosing an IRCCS-accredited facility ensures access to clinical trials for complex cases. These centers often have more experience with rare vasculitis variants.

Patient Consensus: Patients note that university-affiliated hospitals in Pavia and Padua provide faster specialist care. Many recommend booking directly with experts to avoid long emergency room waits.

Italian specialists treat vasculitis using a combination of high-dose glucocorticoids and targeted biologics. Prednisone serves as the primary first-line therapy to manage acute inflammation. Doctors often combine it with Rituximab or Cyclophosphamide to induce remission safely and prevent disease relapse.

• Induction therapy: High-dose pulse Methylprednisolone or Prednisone rapidly controls severe systemic inflammation.
• Biologic agents: Rituximab is frequently preferred over traditional drugs to minimize long-term infertility risks.
• Maintenance medications: Methotrexate and Azathioprine sustain remission once the initial inflammatory phase subsides.
• Targeted treatments: Tocilizumab and Mepolizumab treat specific types like Giant Cell Arteritis or EGPA.

Bookimed Expert Insight: Data from major Italian research hospitals like San Raffaele in Milan shows a shift toward steroid-sparing protocols. These centers integrate Avacopan and early biologics to reduce classic steroid-related side effects like diabetes. Academic institutions in Northern Italy often provide faster access to these emerging complement inhibitors via clinical research trials.

Patient Consensus: Patients note that specialists in Northern Italy prioritize frequent blood monitoring and PET scans to taper steroids quickly. Many suggest confirming drug coverage through the national health system early in the process.

Coverage for vasculitis treatment in Italy depends on your residency and citizenship status. European Union citizens using a European Health Insurance Card receive care under the same terms as local residents. Non-EU visitors generally pay out-of-pocket unless they hold an Italian residency permit.

• EU citizens: Use the European Health Insurance Card for medically necessary specialist care.
• Legal residents: Register with the Servizio Sanitario Nazionale to access covered chronic treatments.
• Rare disease status: Residents with GPA or MPA may receive specific cost exemption codes.
• Private patients: Non-EU foreigners typically require private insurance for elective infusion therapies.

Bookimed Expert Insight: San Raffaele in Milan is a key destination for complex cases. It is one of the few centers with IRCCS accreditation for immune research. This status means they combine clinical care with advanced research activities. For non-resident patients, these institutions often offer lower public rates compared to private hospitals. Always verify if your specific diagnosis qualifies for Italian rare disease exemptions before starting long-term care.

Patient Consensus: Patients note that emergency care is always available regardless of status. Many suggest securing an elective residency visa for long-term treatment to access public health benefits.

Discuss the specific type of vasculitis with your specialist to align with Italian Society of Rheumatology guidelines. Review organ involvement and the necessity of biologic therapies like rituximab for remission. Confirm screening protocols for chronic infections required before starting immunosuppressive treatments in Italian hospitals.

• Treatment guidelines: Confirm if your plan follows SIRT recommendations for large-vessel vasculitis.
• Organ assessment: Discuss current damage to critical organs like kidneys or lungs.
• Biologic therapy: Inquire about using rituximab or tocilizumab for long-term maintenance.
• Screening requirements: Discuss mandatory tuberculosis testing before beginning any biologic infusion cycles.

Bookimed Expert Insight: San Raffaele in Milan serves as a major hub for rare immune diseases. It combines clinical care with research through its IRCCS accreditation. For complex vasculitis cases, this hospital performs over 52,000 operations annually. Patients benefit from the multidisciplinary approach used at large research centers. This ensures rheumatology and nephrology experts co-manage systemic organ involvement effectively.

Patient Consensus: Patients highlight that investing in a private initial visit can reduce wait times from months to weeks. Confirming the specific administrative code for your condition is vital to ensure full medication coverage.

Italy offers vasculitis treatments including biologic agents, immunosuppressants, and therapeutic apheresis. Clinical centres follow guidelines set by the EULAR (European Alliance of Associations for Rheumatology). Major facilities in Milan specialise in rare immune diseases. They provide targeted therapies like Rituximab and tocilizumab for complex cases.

• Specialised apheresis: Clinics perform plasma exchange to remove harmful antibodies from the blood.
• Biologic therapy: Specialists use Rituximab and tocilizumab to target specific immune system proteins.
• Immune specialisation: Ospedale San Raffaele in Milan focuses on rare immune system disorders.
• Steroid-sparing protocols: Doctors use methotrexate or Avacopan to reduce long-term corticosteroid reliance.

Bookimed Expert Insight: Italian research hospitals offer unique advantages for complex vasculitis cases. San Raffaele in Milan is an IRCCS-accredited facility. This means it integrates laboratory research directly with clinical care. Patients there benefit from 18 specialised departments. This multidisciplinary setup is vital for treating multi-organ vasculitis damage effectively.

Leading vasculitis specialists in Italy practice at IRCCS-accredited research hospitals in Milan, Florence, and Udine. These centres specialise in rare immune disorders and systemic autoimmune diseases. Centres like San Raffaele in Milan combine clinical care with research into complex vascular cases.

• Milan expertise: San Raffaele treats 300,000 patients annually and focuses on rare immune disorders.
• Florence hub: Careggi University Hospital houses a dedicated Reference Centre for Systemic Autoimmune Diseases.
• Research focus: Udine specialist clinics lead research into ANCA-associated vasculitis healthcare burdens.
• Specialist teams: Care involves a multidisciplinary mix of rheumatologists, nephrologists, and pulmonologists.

Bookimed Expert Insight: Italian vasculitis care is concentrated in IRCCS-accredited facilities such as San Raffaele. These institutions receive double the oversight. They act as both hospitals and federally funded research centres. This dual status lets patients access emerging protocols for rare immune diseases early. Choosing an IRCCS centre in Milan or Florence links you to guideline authors. Our data shows these academic hubs handle over 50,000 surgical procedures yearly. This ensures high-volume experience for complex cases.

Rituximab is accessible in Italy for treating ANCA-associated vasculitis. Italian medical units use it for induction and maintenance of remission. Specialised hospital units oversee these infusions. These biologics often replace traditional, higher-toxicity treatments. Access depends on a confirmed diagnosis from a specialist.

• Clinical indications: Authorised for granulomatosis with polyangiitis and microscopic polyangiitis.
• Biosimilar options: Two approved rituximab biosimilars provide cost-effective alternatives to originators.
• Specialised centres: San Raffaele in Milan treats rare immune system diseases.
• Monitoring protocols: The Italian Medicines Agency tracks usage via central registers.
• Alternative biologics: Tocilizumab is used specifically for treating giant cell arteritis.

Bookimed Expert Insight: Italian centres like San Raffaele combine research with clinical care. These hospitals hold IRCCS accreditation from the Italian Ministry of Health. This status means patients access therapies developed through active clinical research. This is vital for complex cases like rare immune disorders.

Italian specialists manage long-term vasculitis care through a multidisciplinary approach at accredited research hospitals. Management involves steroid-sparing maintenance therapies to prevent relapses. These include biologics and rituximab. Leading centres like San Raffaele in Milan use therapeutic apheresis and research-driven protocols to stabilise systemic inflammation.

• Maintenance therapy: Doctors use biologics such as rituximab or avacopan to reduce long-term steroid use.
• Clinical monitoring: Patients undergo regular blood tests, urine checks, and imaging to track organ health.
• Specialised techniques: Specialists use plasmapheresis and selective apheresis to remove harmful antibodies during flares.
• Research access: IRCCS-accredited hospitals provide access to clinical trials for rare immune system diseases.

Bookimed Expert Insight: Public hospitals manage most cases. However, choosing a facility with IRCCS accreditation is vital. San Raffaele holds this national research designation and serves 300,000 patients annually. This research-meets-clinical status gives patients earlier access to emerging stem cell therapies and experimental protocols.

Patient Consensus: Patients in Italy emphasise establishing a clear relapse plan with their specialist before finishing initial treatment. Regular coordination between rheumatologists and nephrologists is standard to manage potential kidney complications effectively.

Patients undergoing vasculitis treatment in Italy must adopt an anti-inflammatory diet. This includes healthy fats and whole vegetables. Clinicians also recommend infection control measures while on immunosuppressants. Regular low-impact exercise like walking helps maintain circulation. Bone health requires increased calcium intake during steroid use.

• Anti-inflammatory focus: Use olive oil and fruits to reduce systemic inflammation naturally.
• Steroid management: Limit refined sugars to control weight gain from prednisone.
• Bone protection: Eat yoghurt and leafy greens to prevent osteoporosis during treatment.
• Low-impact activity: Perform swimming or cycling to support joints and blood flow.
• Infection prevention: Maintain strict hygiene and avoid crowds while taking immunosuppressive medications.

Bookimed Expert Insight: Italian research hospitals like San Raffaele in Milan specialise in rare immune diseases. They often combine standard drug therapies with procedures like plasmapheresis. This plasma exchange helps clear harmful antibodies quickly. Patients at these IRCCS-accredited centres receive care backed by active clinical research.